London 7th September : The chances of developing myocarditis in males aged between 16 and 19 years is 1 in 15,000 following the third dose of the Pfizer-BioNTech Covid-19 vaccination However, the cases are very rare and mild, as per an investigation that was conducted in Israel.Myocarditis is an inflammation of the middle layer of the wall of the myocardium, the heart muscle.
The condition is rare and can cause temporary or permanent weakness to the heart muscle as well as the electrical system of the heart, which helps keep the heart running.
“It is crucial to know the connection between this uncommon heart condition and the Covid-19 vaccines, so that we can keep track of the frequency of myocarditis, and pay special attention to those most at risk, according to the study’s lead researcher Dror Mevorach, chair of the Israeli Ministry of Health Committee for “Identifying Myocarditis as an adverse Effect of mRNA vaccines’ in Jerusalem.
Prior to the outbreak was discovered, it was estimated that around 10 to 20 people in 100,000 had been diagnosed with myocarditis every year according to the American Heart Association (AHA).
The rate of myocarditis after vaccination in Israel was low, but was primarily in young males following the second Covid-19 vaccine and suggests a possible link between myocarditis and the vaccine according to research published by Israel’s Ministry of Health.
The risk difference decreased significantly between the second and third doses for both genders and across all age groups.
The researchers stated that the most likely explanation is that people who contracted myocarditis following the second dose of Covid-19 didn’t receive a second shot as per the medical advice in Israel.
“The second explanation could be the length of interval between doses: the first and subsequent doses are given at a time of three weeks but the time between two doses and a booster was 20 to 24 weeks” Mevorach said.Mevorach.
Researchers believe that more research is needed to better understand the factors that may cause young males to develop myocarditis following the vaccination with Covid-19 and the pathophysiological causes.
rpd/na/
